REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

Life Fusion Inc. (Taiwan, China)

Main Activities: Medicinal and Botanical Manufacturing
Full name: Life Fusion Inc. Profile Updated: August 27, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Chinese Download a sample report

Life Fusion Inc. develops collagen-based products that are used in biomedical and skincare. The company was founded in 2009 and is headquartered in Tainan City, Taiwan.

Headquarters
3F, No. 9, Nanke 2Nd Rd., Xinshi Dist
Tainan City; Tainan City;

Contact Details: Purchase the Life Fusion Inc. report to view the information.

Website: http://www.lifefusion.com.tw

Basic Information
Total Employees:
Purchase the Life Fusion Inc. report to view the information.
Outstanding Shares:
Purchase the Life Fusion Inc. report to view the information.
Financial Auditors:
Purchase the Life Fusion Inc. report to view the information.
Incorporation Date:
May 14, 2009
Key Executives
Purchase this report to view the information.
Chairman
Purchase this report to view the information.
Director/Member of the Board
Ownership Details
Purchase this report to view the information.
6.84%
Purchase this report to view the information.
5.26%
Purchase this report to view the information.
3.17%
Purchase this report to view the information.
3.16%
Purchase this report to view the information.
2.63%
Subsidiaries
惠合再生醫學有限公司 (China)
100%
深圳嬌原商貿有限公司 (China)
100%
威豪成功股份有限公司 (China)
52%
Company Performance
Financial values in the chart are available after Life Fusion Inc. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency TWD. Absolute financial data is included in the purchased report.
Net sales revenue
-15.2%▼
Total operating revenue
-11.2%▼
Operating profit (EBIT)
-33.4%▼
EBITDA
-63.32%▼
Net Profit (Loss) for the Period
-41.54%▼
Total assets
-16.89%▼
Total equity
N/A
Operating Profit Margin (ROS)
-33.85%▼
Net Profit Margin
-38.26%▼
Return on Equity (ROE)
N/A
Debt to Equity Ratio
N/A
Quick Ratio
-0.46%▼
Cash Ratio
-0.27%▼

Similar companies

Sinphar Pharmaceutical Co., Ltd.
 
Microbio Co., Ltd.

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo